Author: JayCurrie

Skyharbour Discovers New High Grade Uranium Mineralization at Maverick Zone including 5.39% U3O8 over 1.0 metre within 2.07% U3O8 over 3.5 metres; Summer 2018 Drill Program Upcoming

JayCurrie
V.SYH, Skyharbour, Uranium,

Vancouver, BC – Skyharbour Resources Ltd. (TSX-V: SYH)(OTCQB: SYHBF)(Frankfurt:SC1P) (the “Company”) is pleased to announce the results from its 2018 winter/spring diamond drilling program at its flagship 35,705 hectare Moore Uranium Project, located approx.15 kilometres east of Denison Mine’s Wheeler River project and near regional infrastructure on the southeast side of the Athabasca Basin, Saskatchewan. Drillhole ML18-08 intersected high grade uranium mineralization within the Main Maverick Zone consisting of 5.39% U3O8 over 1.0 metre within an interval containing 2.07% U3O8 over 3.5 metres. This mineralization occurs at the unconformity from 265.8 to 269.3 metres downhole. Also of note is hole ML18-09 which intersected uranium mineralization at the unconformity in the Maverick East Zone, a new high grade lens discovered by Skyharbour last year. This hole returned a grade equivalent of 3.07% U3O8 over 1.8 metres from an interval containing a grade equivalent of 1.01% U3O8 over 6.3 metres. read more

Standard Lithium Commissions Hunt Guillot & Associates LLC For Engineering Services For Arkansas Pilot Plant

JayCurrie
V.SLL, Standard Lithium

VANCOUVER, British Columbia, June 14, 2018 (GLOBE NEWSWIRE) — Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSX-V:SLL) (FRA:S5L) is pleased to announce that they have engaged Hunt Guillot & Associates LLC (HGA) of Ruston, Louisiana, to provide engineering services for site preparation, utility connections and brine supply/disposal pipeline connections at the Company’s Pilot Plant site location in El Dorado, Southern Arkansas.  HGA experts are very familiar with the plant location, and their scope of work includes geotechnical investigations and civil infrastructure required to site the pilot plant modules; design and tendering of any structures required to house and protect the pilot plant infrastructure; all utility and brine pipeline interconnections; and pilot plant installation. read more

NEXGEN ANNOUNCES POSITIVE RESULTS FROM ARROW PROJECT STUDIES

JayCurrie
T.NXE, NexGen, uranium
Cision

VANCOUVER, June 13, 2018 /CNW/ – NexGen Energy Ltd. (“NexGen” or the “Company”) (TSX: NXE) (NYSE MKT: NXE) is pleased to report the positive results from Pre-Feasibility-stage technical studies including metallurgical, geotechnical, and hydrogeological assessments. These studies were conducted on the basement-hosted Arrow Deposit, located on the Company’s 100% owned Rook I project in Saskatchewan’s Athabasca Basin. read more

Bayhorse Silver Achieves Near Total Silver Recovery With Two Stage Leaching, Bayhorse Silver Mine, Oregon, USA

JayCurrie
Bayhorse silver, V.BHS
info

Vancouver, British Columbia–(Newsfile Corp. – June 6, 2018) – Bayhorse Silver Inc. (TSXV: BHS) (the “Company” or “Bayhorse”) has achieved near total silver recovery (NTSR) from the recent two stage leaching test program conducted for the Company by Richard Hammen, Ph.D. Chemistry, on its Bayhorse Silver Mine, Oregon, USA. The Company is in the process of establishing the effectiveness of the processing method at commercial levels of production. read more

C.HUGE All-Time Daily Volume Record Broken and Thanks to All Shareholders

JayCurrie
Canada gold, junior mining companies
TORONTO, May 30, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), is pleased to report that on its first day of trading (May 29, 2018) the company traded exactly 78,477,861 Class B subordinate voting shares on the CSE (Canadian Securities Exchange), 7,592,500 on AQC-Lit, 1,680,000 on AQC-Neo, 136,000 on CHIX, 236,500 on CX2 and 25,013,000 on the TriAct exchange for an aggregate total of 113,135,861 shares traded. This is the largest total quantity of share volume traded by a CSE listed issuer by over 27% above the recorded all-time high of 88,846,729, on the first day of trading, as confirmed by the CSE.The company wishes to thank all its shareholders and stakeholders for their support to date, which has resulted in a record-breaking launch into the Canadian cannabis marketplace.About FSD Pharma Inc.FSD Pharma, owns, through its wholly-owned subsidiary FV Pharma Inc., a license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations (ACMPR) which was originally granted on October 13, 2017. Headquartered at the former Kraft plant in Cobourg, Ontario, approximately an hour’s drive from Toronto, FSD Pharma’s management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility in the world. FSD Pharma intends to target all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development. Please visit www.fsdpharma.com for more information.Forward-Looking InformationCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Corporation’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the development of the Corporation’s indoor cannabis facility and its business goals and objectives. The forward-looking information contained in this press release is made as of the date hereof, and the Corporation is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking-information. The foregoing statements expressly qualify any forward-looking information contained herein.Thomas FairfullChief Executive Director, FSD Pharma Inc.SOURCE FV Pharma IncFor further information: Investor Relations, Phone : 416-433-2166, Email:IR@fsdpharma.com, Website: www.fsdpharma.com

Marathon Gold Files Positive NI 43-101 Technical Report (PEA) for the Valentine Lake Gold Project, Newfoundland

JayCurrie
T.MOZ, Marathon Gold

TORONTO, May 30, 2018 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”) (TSX:MOZ) is pleased to announce that it has filed a National Instrument 43-101 (“NI 43-101”) Technical Report of the Preliminary Economic Assessment in respect of the Company’s Valentine Lake Gold Project. The technical report is available for review on SEDAR (www.sedar.com) and on the Company’s website (www.marathon-gold.com) read more